As post-tamoxifen therapy, letrozole cuts breast cancer recurrence 43%

News
Article

Letrozole therapy, in follow-up to 5 years of tamoxifen treatment, significantly improves disease-free survival compared to placebo, according to a study published in The New England Journal of Medicine.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.